Call: 1-800-887-8100

 

New here?
Please register Already a member?
Sign in now

 
About COPAXONE(R) Taking COPAXONE(R) Your Immune System About Multiple Sclerosis About Shared Solutions(R) Available Therapies
Share Print

Immune Smart

Available Therapies

Making a smart therapy choice means weighing important factors:


• Is this therapy safe for my body? Can I safely use it long term? • Does this therapy allow healthy immune cells to function normally, protecting me from infection, disease, and other health complications? • Does this therapy have a proven track record of reducing the frequency of relapses and the formation of new lesions as detected by magnetic resonance imaging (MRI)? • How does this therapy make me feel? Can I continue living life as normally as possible?

Approved therapies to treat RRMS

Immune Smart


  • COPAXONE®: A unique RRMS therapy thought to modify the immune response by helping to restore balance in the immune systema

   Interferons: Modify the immune system by preventing immune cells from entering
   the central nervous system (CNS).b,c

  • Avonex® (interferon beta-1a)
  • Betaseron® (interferon beta-1b)
  • Extavia® (interferon beta-1b)
  • Rebif® (interferon beta-1a)

  • GilenyaTM (fingolimod): Believed to work by preventing immune cells from leaving the lymph nodes. As a result, immune cells in the CNS and the body are reducedd

  • Tysabri® (natalizumab): Modifies the immune response by reducing the movement of immune cells into the CNSe

  • Novantrone® (mitoxantrone): An immunosuppressant that is approved for use in patients with worsening RRMS, secondary-progressive MS, or progressive-relapsing MS

Approved therapies at a glance

Click here for an overview of all approved RRMS therapies.

Remember that these disease-modifying therapies don't treat symptoms of MS. You and your doctor can work together on strategies to deal with symptoms. You can also get tips from others with MS who have gone through what you're experiencing.

References:
a. COPAXONE® (glatiramer acetate injection) prescribing information. Teva Neuroscience, Inc. b. Bennett JL, Stüve O. Clin Neuropharmacol. 2009;32(3):121-132. c. Betaseron® (interferon beta-1b) prescribing information. Bayer HealthCare Pharmaceuticals Inc. d. Gilenya™ (fingolimod) prescribing information. Novartis Pharmaceuticals Corportation. e. Tysabri® (natalizumab) prescribing information. Biogen Idec Inc.




Current rating: 3.4 (12 ratings)
COP100006229/102403
  • COPAXONE® (glatiramer acetate injection) is indicated for the reduction of the frequency of relapses in relapsing-remitting multiple sclerosis, including patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.

Important Safety Information About COPAXONE®

  • The most common side effects of COPAXONE® are redness, pain, swelling, itching, or a lump at the site of injection, flushing, rash, shortness of breath, and chest pain. These reactions are usually mild and seldom require professional treatment. Be sure to tell your doctor about any side effects.

    Some patients report a short-term reaction right after injecting COPAXONE®. This reaction can involve flushing (feeling of warmth and/or redness), chest tightness or pain with heart palpitations, anxiety, and trouble breathing. These symptoms generally appear within minutes of an injection, last about 15 minutes, and go away by themselves without further problems.

    A permanent indentation under the skin at the injection site may occur, due to a local destruction of fat tissue. Be sure to follow proper injection technique and inform your doctor of any skin changes.

    After you inject COPAXONE®, call your doctor right away if you develop hives, skin rash with irritation, dizziness, sweating, chest pain, trouble breathing, severe pain at the injection site or other uncomfortable changes in your general health. Do not give yourself any more injections until your doctor tells you to begin again.

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

#1 Prescribed RRMS therapy in the US*

Suggested articles

Benefits & Insurance Assistance

COPAXONE Co-pay Solutions™

Therapy and Immune Health

10 Tips for CarePartners

Choosing a Therapy

Your MS Online Planner

My recent articles

Portraits of MS

Your Immune System

Team COPAXONE®

Insurance FAQs

MS therapy and your
immune health: Why the two are so important.
COPAXONE® is proven effective for the long term with 19 years of clinical experience.†,‡  Read more.
More SolutionsTrack your injections, your appointments ... your life. Set up your More Solutions Planner.
Clay Walker, country music artist on COPAXONE®
for RRMS, talks about
the importance of early
MS treatment.

Clay Walker

Read more.

HeathAfter careful consideration of each of the treatments and time spent talking with my neurologist and others on the treatments, I chose COPAXONE®. My decision to start COPAXONE® was a simple one because it was proven effective and well-tolerated.

—Heath C., on COPAXONE® for RRMS since 1998

Individual results may vary.

 

†Data on file. Teva Neuroscience, Inc. ‡Ford C, Goodman AD, Johnson K, et al. Mult Scler. 2010;16(3):342-350.
master_PDF.png  Download Adobe Acrobat
*IMS Health National Prescription Audit, May 2011. Data is proprietary to IMS Health.
 

COPAXONE® is a registered trademark of Teva Pharmaceutical Industries Ltd. Shared Solutions® is a registered trademark of Teva Neuroscience, Inc. autoject® 2 for glass syringe is a registered trademark of Owen Mumford, Ltd. COPAXONE CO-PAY SOLUTIONS™ is a trademark of Teva Pharmaceutical Industries Ltd. © 2011, Teva Neuroscience, Inc. All Rights Reserved. This site is intended for US residents only.

The brands listed are the trademarks and registered trademarks of their respective owners.